Post by Brandon Capital

💡𝐈𝐭 𝐢𝐬 𝐧𝐨𝐰 𝐭𝐰𝐨 𝐰𝐞𝐞𝐤𝐬 𝐨𝐧 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐂𝐔𝐑𝐄𝐚𝐭𝐨𝐫 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐡𝐨𝐰𝐜𝐚𝐬𝐞, 𝐚𝐧𝐝 𝐰𝐞 𝐚𝐫𝐞 𝐬𝐭𝐢𝐥𝐥 𝐞𝐧𝐞𝐫𝐠𝐢𝐬𝐞𝐝 𝐛𝐲 𝐭𝐡𝐞 𝐝𝐚𝐲, 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐝 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧𝐬 𝐰𝐢𝐭𝐡 𝐚𝐧𝐝 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬💡 🚀 The pitches from funded companies were amazing and some incredible stories are yet to play out. 🚀 CUREator operates as a national translational and venture-building platform, bridging the gap between research and investment readiness. Over the past four years, that model has translated into significant impact across company formation, capital mobilisation, clinical translation and national capability-building. The funding supports individual companies, but the impact extends across the broader national ecosystem. These numbers matter because they show impact of our incubator at multiple levels: ✅𝐂𝐚𝐭𝐚𝐥𝐲𝐬𝐢𝐧𝐠 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐅𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 67 SMES & projects funded 28 new Australian start-ups formed 💸𝐌𝐨𝐛𝐢𝐥𝐢𝐬𝐢𝐧𝐠 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 𝐚𝐧𝐝 𝐂𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥𝐢𝐬𝐚𝐭𝐢𝐨𝐧 𝐏𝐚𝐭𝐡𝐰𝐚𝐲𝐬 >$75m in non-dilutive funding committed >$300m in private capital raised 🚀𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐚𝐧𝐬𝐥𝐚𝐭𝐢𝐨𝐧 >20 Clinical trials and implementations >28,000 patients treated or benefitted 🏗️ 𝐁𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐀𝐮𝐬𝐭𝐫𝐚𝐥𝐢𝐚’𝐬 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐂𝐚𝐩𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐂𝐚𝐩𝐚𝐜𝐢𝐭𝐲                                                  >490 Highly skilled jobs supported >85 Unique collaborations across universities, MRIs and hospitals 💡𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐈𝐧𝐭𝐞𝐥𝐥𝐞𝐜𝐭𝐮𝐚𝐥 𝐏𝐫𝐨𝐩𝐞𝐫𝐭𝐲 >60 patents granted >85 patents filed 💰𝐑𝐞𝐝𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐧𝐠 𝐕𝐚𝐥𝐮𝐞 𝐢𝐧𝐭𝐨 𝐭𝐡𝐞 𝐋𝐨𝐜𝐚𝐥 𝐄𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦 90% of grant funding #BioMedTech #Innovation #CUREatorshowcase Amanda Vrselja Aaron DeBonoMarium RanaChristina KulisPatricia Rueda

Video Content